Isatuximab EU Approval Decision Due
Sanofi Product Is On List of Hopefuls At CHMP Meeting
Recommending new medicines for approval and allowing sponsors of others extra time to answer outstanding questions are among the many tasks on the agenda of the March meeting of European Medicines Agency's key scientific committee, the CHMP. The meeting has been taking place, remotely, this week.